ABBV vs EW
By Alex · Tickerpine
AbbVie Inc. vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | EW |
|---|---|---|
| Price | $253.35 | $90.78 |
| Market cap | $447.62B | $52.27B |
| P/E ratio | 123.6 | 49.1 |
| ROE | — | 10.46% |
| Profit margin | 5.79% | 17.39% |
| Revenue growth | 12.40% | 16.70% |
| Dividend yield | 2.73% | — |
| Beta | 0.31 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs EW in plain English
- ABBV is the bigger company — about 8.6× the market cap of EW.
- EW is cheaper on earnings (P/E 49.1 vs 123.6).
- EW is growing revenue faster (17% vs 12%).
- ABBV pays a dividend (2.73%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.